Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy

Clinical trial NCT06138743 · RECRUITING

Trial details

NCT number: NCT06138743
Sponsor: Sarepta Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myotonic Dystrophy 1

Start date: 2024-03-04
Primary completion: 2026-12-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.